Second line drug mutation patterns observed among MDR-TB using Genotype MTBDR <i>plus®.</i>

Second line drug mutation patterns observed among MDR-TB using Genotype MTBDR <i>plus®.</i>

<p>Second line drug mutation patterns observed among MDR-TB using Genotype MTBDR <i>plus®.</i></p>

Saved in:

Bibliographic Details
Main Author:	Stephen Ofori Yirenkyi (14393505) (author)
Other Authors:	Osmanu Taufik (21395095) (author), Roger Laryea (21395098) (author), Amanquador Acquah-Keelson (21395101) (author), Japheth Awuletey Opintan (18320072) (author), Gloria Ivy Mensah (9649211) (author)
Published:	2025
Subjects:	Medicine Genetics Molecular Biology Biotechnology Cancer Science Policy Infectious Diseases Virology provide baseline data however inadequate data greater accra region bactec mgit system aminoglycosides resistance respectively amino acid changes tb drugs using tb control programs 4 %; however predominant mutations associated associated resistant mutations 171 archived isolates 171 isolates came extensively drug resistant tb among mdr male tb patients tb </ p tb patients 4 %) mutations responsible resistant tuberculosis sl </ rrwt2 </ rrs </ rpob </ plus </ katg </ gyramut3a </ gyra </ xlink "> sustained surveillance study sought position 1484 line anti january 2016 impacts negatively genotypic susceptibility genotypic analysis genotype mtbdr december 2020 also determined a90v ), >, mtbdr 9 %). 8 %). 50 %) 5 %) 3 %)
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Cannot write session to /tmp/vufind_sessions/sess_eia8hekir0et0k9s2c0qbsmgji